GENOCEA BIOSCIENCES, INC. 3 SEC Filings

Filed On	Filing
07 Mar 2022	Form 3: Lunger John, Director No securities owned
28 Sep 2021	Form 3: Herron Jennifer Lyn, Director No securities owned
23 Feb 2021	Form 3: Sumer Jacquelyn L, CHIEF LEGAL & COMPLIANCE OFF Holds 5,500 shares of Common Stock
27 Jan 2021	Form 3: Stapleton Raymond D Jr, EVP PHARM SCI & MFG No securities owned
18 Feb 2020	Form 3: Schwab Gisela, Director No securities owned
07 Mar 2019	Form 3: Duvall Diantha, CHIEF FINANCIAL OFFICER No securities owned
25 Feb 2019	Form 3: Glaxosmithkline Plc, 10% owner Holds 12,069,937 shares of Common Shares
14 Dec 2018	Form 3: Aakalu Girish N, CHIEF BUSINESS OFFICER No securities owned
16 Oct 2018	Form 3: Carroll Pamela, SVP IMMUNO-ONCOLOGY
12 Oct 2018	Form 3: Singh Narinderjeet, SENIOR VP, PS&M Holds 20,000 shares of Common Stock
01 Oct 2018	Form 3: Davis Thomas Andrew, CHIEF MEDICAL OFFICER No securities owned
20 Sep 2018	Form 3: Meisner Derek M, SENIOR VP AND GENERAL COUNSEL No securities owned
17 Jul 2018	Form 3: Chang Carmen, 10% owner Holds 25,000,000 shares of Common Stock
17 Jul 2018	Form 3: Behbahani Ali, 10% owner Holds 25,000,000 shares of Common Stock
28 Jun 2018	Form 3: Alfieri Michael, Principle Financial Officer
12 Feb 2018	Form 3: Behbahani Ali, Director No securities owned
23 Jan 2018	Form 3: Viswanathan Ravi, 10% owner Holds 25,000,000 shares of Common Stock
23 Jan 2018	Form 3: Sonsini Peter W., 10% owner Holds 25,000,000 shares of Common Stock
23 Jan 2018	Form 3: Sandell Scott D, 10% owner Holds 25,000,000 shares of Common Stock
23 Jan 2018	Form 3: Sakoda Jon, 10% owner Holds 25,000,000 shares of Common Stock

Comments